IngentaConnect Progress in haematopoietic stem cell transplantation for multiple...

Authors: Gahrton, G.¹; Björkstrand, B.¹

Source: Journal of Internal Medicine, Volume 248, Number 3, September 2000 , pp. 185-201(17)

Abstract:

Gahrton G. & Björkstrand B. (Departments of Medicine and Hematology, Karolinska Institutet and Huddinge University Hospital, Huddinge, Sweden). Progress in haematopoietic stem cell transplantation for multiple myeloma (Review). J Intern Med 2000; 248: 185-201.

High-dose myeloablative treatment followed by autologous haematopoietic stem cell transplantation has significantly improved survival of patients younger than 65 years of age with multiple myeloma as compared with conventional chemotherapy. However, all patients seem to relapse and molecular remissions are rare.

Results of allogeneic transplantation, still hampered by high transplant-related mortality, have improved dramatically over the last 5-6 years and this is an option for patients younger than 50-55 years old. The relapse rate is lower than with autologous transplantation and molecular remissions are frequent. Some patients are still in complete haematological remission more the 10 years following transplantation.

Autologous transplantation followed by nonmyeloablative allogeneic transplantation is on trial and may be a way to eventually cure a fraction of younger patients with multiple myeloma.

Keywords: allogeneic bone marrow transplantation; allogeneic peripheral blood stem cell transplantat; autologous haematopoietic stem cell transplantatio; multiple myeloma

Document Type: Research article

DOI: 10.1046/j.1365-2796.2000.00706.x

Affiliations: 1: Departments of Medicine and Hematology, Karolinska Institutet and Huddinge University Hospital, Huddinge, Sweden

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com